HighTower Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,089	Closed	-$52.1K	–	3879
2025 Q4	$52.1K	Buy	19,089 +7,718	+68%	+$17.9K	﹤0.01%	3575
2025 Q3	$24.7K	Sell	11,371 -177,507	-94%	-$419K	﹤0.01%	3659
2025 Q2	$325K	Buy	188,878 +111,312	+144%	+$277K	﹤0.01%	2861
2025 Q1	$258K	Sell	77,566 -1,672	-2%	-$8.62K	﹤0.01%	2984
2024 Q4	$586K	Buy	79,238 +2,951	+4%	+$27.4K	﹤0.01%	2352
2024 Q3	$716K	Buy	76,287 +84	+0.1%	+$796	﹤0.01%	2138
2024 Q2	$611K	Buy	+76,203	New	+$817K	﹤0.01%	2174
2022 Q3	–	Sell	-12,050	Closed	-$132K	–	3266
2022 Q2	$132K	Buy	12,050 +769	+7%	+$10.1K	﹤0.01%	2723
2022 Q1	$189K	Buy	11,281 +845	+8%	+$13.1K	﹤0.01%	2857
2021 Q4	$198K	Sell	10,436 -658	-6%	-$14.5K	﹤0.01%	2784
2021 Q3	$275K	Sell	11,094 -3,093	-22%	-$72.9K	﹤0.01%	2475
2021 Q2	$368K	Buy	+14,187	New	+$369K	﹤0.01%	2235
2020 Q2	–	Sell	-7,535	Closed	-$227K	–	2481
2020 Q1	$227K	Buy	+7,535	New	+$200K	﹤0.01%	1722
2019 Q3	–	Sell	-13,103	Closed	-$308K	–	2472
2019 Q2	$308K	Buy	+13,103	New	+$197K	﹤0.01%	1789